Partial Knee Replacement for Osteoarthritis
What You Need to Know Before You Apply
What is the purpose of this trial?
To evaluate the non-inferiority of the cementless Engage Partial Knee System compared to cemented Engage Partial knee System.
Who Is on the Research Team?
David A Crawford, MD
Principal Investigator
JIS Research Institute
Are You a Good Fit for This Trial?
This trial is for adults over 21 with severe knee osteoarthritis or avascular necrosis limited to one part of the knee, who haven't found relief through other treatments and have a BMI under 40. They must be able to follow post-op care and return for check-ups. Excluded are those with certain diseases, previous knee surgeries that failed, allergies to metal or cement, pregnant women, drug abusers, heavy smokers, or anyone unlikely to complete the study.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo unicompartmental knee arthroplasty with either cemented or cementless fixation
Follow-up
Participants are monitored for safety and effectiveness after treatment, including pain score, implant survivorship, range of motion, and KOOS JR score
What Are the Treatments Tested in This Trial?
Interventions
- Engage Partial Knee
Find a Clinic Near You
Who Is Running the Clinical Trial?
JIS Research Institute
Lead Sponsor
Smith & Nephew, Inc.
Industry Sponsor
Dr. Maria Berkman
Smith & Nephew, Inc.
Chief Medical Officer since 2023
MD from Harvard Medical School
Dr. Deepak Nath
Smith & Nephew, Inc.
Chief Executive Officer since 2022
PhD in Theoretical Mechanics, University of California, Berkeley